Literature DB >> 2937514

The nucleus basalis of Meynert.

C Ezrin-Waters, L Resch.   

Abstract

The nucleus basalis of Meynert has been studied extensively in the recent literature. Interest in this nucleus has resulted from the discovery that it is a major source of cortical cholinergic input and that there is neuronal loss in the nucleus basalis in some dementing illnesses. Consistent and severe involvement of the nucleus basalis of Meynert has been found in Alzheimer's disease and in the dementia accompanying Parkinson's disease. Occasional involvement is present in other dementing illnesses, such as progressive supranuclear palsy, Parkinsonism-Dementia complex of Guam, dementia pugilistica, Pick's disease, Korsakoff's syndrome, Down's Syndrome and Creutzfeldt-Jacob disease. Huntington's disease spares this nucleus. However, the role of the nucleus in cognitive function is as yet undetermined. Even its alteration with normal aging remains controversial. This review details the pathological studies of this region to date, with particular emphasis on the dementias. Its role in the dementias of Alzheimer's disease and Parkinson's disease is specifically addressed.

Entities:  

Mesh:

Year:  1986        PMID: 2937514     DOI: 10.1017/s0317167100035721

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

1.  Verapamil prevents, in a dose-dependent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis.

Authors:  Miroljub Popović; Maria Caballero-Bleda; Natalija Popović; Luis Puelles; Thomas van Groen; Menno P Witter
Journal:  Exp Brain Res       Date:  2005-11-23       Impact factor: 1.972

2.  Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease.

Authors:  San Jung; Chris Zarow; Wendy J Mack; Ling Zheng; Harry V Vinters; William G Ellis; Scott A Lyness; Helena C Chui
Journal:  Arch Neurol       Date:  2012-07

Review 3.  Neuropathology in movement disorders.

Authors:  W R Gibb
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

4.  Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients.

Authors:  D W Dickson; P Davies; R Mayeux; H Crystal; D S Horoupian; A Thompson; J E Goldman
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant α-synuclein.

Authors:  Sufang Zhang; Qian Xiao; Weidong Le
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.